Novartis In Advanced Talks to Acquire Israeli Stem Cell Developer Gamida-Cell – Jewish Business News

Novartis In Advanced Talks to Acquire Israeli Stem Cell Developer Gamida-CellJewish Business NewsStem cell therapies developer Gamida-Cell Ltd. has received an acquisition offer from an international pharma company, Novartis AG (NYSE:NVS; LSE: NOV; SWX: NOVZ). Elbit Medical Technologies, which has a 30.8 percent share in Gamida, said in a Israel s Gamida Cell gets buyout offer [ ]
http://blog.zandcell.com/novartis-in-advanced-talks-to-acquire-israeli-stem-cell-developer-gamida-cell-jewish-business-news/?utm_source=rss&utm_medium=rss&utm_campaign=novartis-in-advanced-talks-to-acquire-israeli-stem-cell-developer-gamida-cell-jewish-business-news